Josefine Bertz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Josefine Bertz has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Lars Matthias Ittner
Dementia Research Centre, Macquarie University, NSW 2109, Australia
9 shared publications - Arne Ittner
Dementia Research Unit, Department of Anatomy, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia
8 shared publications Walter Born
Univ Zurich, Balgrist Univ Hosp, Dept Orthoped, Lab Orthoped Res, Forchstr 340, CH-8008 Zurich, Switzerland
6 shared publicationsBruno Fuchs
Univ Zurich, Balgrist Univ Hosp, Dept Orthoped, Lab Orthoped Res, Forchstr 340, CH-8008 Zurich, Switzerland
5 shared publications- Yazi D. Ke
Dementia Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences Macquarie University Sydney New South Wales Australia
5 shared publications - Anne Poljak
Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW, Australia
3 shared publications
Latest Publications
- Open Access
- 17 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Tau T205 phosphorylation modulates engram cell recruitment and remote memory in mice
Memory loss is linked to failure of the engram, the physical substrate associated with a specific memory. Tau is a microtubule associated protein best known for its central role in neurodegenerative dementias, yet its physiological function in memory formation remains poorly understood. In this work, we show that tau is crucial for forming long lasting memories in mice. Site-specific tau phosphorylation at threonine-205 (T205) is induced by memory encoding and is required for remote memory formation. Tau T205 phosphorylation regulates engram cell, physical unit of memory storage, recruitment and constrains extraneous local cell activation, thereby promoting efficient memory recall. Tau selectively links sensory cue presentations to the encoding ensemble, as optogenetic retrieval of remote memory is tau-independent. Pathogenic tau within active cell ensembles induces aberrant local activation and causes anterograde or retrograde amnesia when present during an encoding or recall time window, respectively. Together, these findings identify a direct physiological role for tau in engram ensemble regulation and establish a mechanistic link between tau dysfunction and memory loss.
- 17 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessTau T205 phosphorylation modulates engram cell recruitment and remote memory in mice
Memory loss is linked to failure of the engram, the physical substrate associated with a specific memory. Tau is a microtubule associated protein best known for its central role in neurodegenerative dementias, yet its physiological function in memory formation remains poorly understood. In this work, we show that tau is crucial for forming long lasting memories in mice. Site-specific tau phosphorylation at threonine-205 (T205) is induced by memory encoding and is required for remote memory formation. Tau T205 phosphorylation regulates engram cell, physical unit of memory storage, recruitment and constrains extraneous local cell activation, thereby promoting efficient memory recall. Tau selectively links sensory cue presentations to the encoding ensemble, as optogenetic retrieval of remote memory is tau-independent. Pathogenic tau within active cell ensembles induces aberrant local activation and causes anterograde or retrograde amnesia when present during an encoding or recall time window, respectively. Together, these findings identify a direct physiological role for tau in engram ensemble regulation and establish a mechanistic link between tau dysfunction and memory loss.
- Open Access
- 24 September 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 14296
Neuronal MAP kinase p38α inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviour
Modulation of behavioural responses by neuronal signalling pathways remains incompletely understood. Signalling via mitogen-activated protein (MAP) kinase cascades regulates multiple neuronal functions. Here, we show that neuronal p38α, a MAP kinase of the p38 kinase family, has a critical and specific role in modulating anxiety-related behaviour in mice. Neuron-specific p38α-knockout mice show increased levels of anxiety in behaviour tests, yet no other behavioural, cognitive or motor deficits. Using CRISPR-mediated deletion of p38α in cells, we show that p38α inhibits c-Jun N-terminal kinase (JNK) activity, a function that is specific to p38α over other p38 kinases. Consistently, brains of neuron-specific p38α-knockout mice show increased JNK activity. Inhibiting JNK using a specific blood-brain barrier-permeable inhibitor reduces JNK activity in brains of p38α-knockout mice to physiological levels and reverts anxiety behaviour. Thus, our results suggest that neuronal p38α negatively regulates JNK activity that is required for specific modulation of anxiety-related behaviour.
- 24 September 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 14296
Open AccessNeuronal MAP kinase p38α inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviour
Modulation of behavioural responses by neuronal signalling pathways remains incompletely understood. Signalling via mitogen-activated protein (MAP) kinase cascades regulates multiple neuronal functions. Here, we show that neuronal p38α, a MAP kinase of the p38 kinase family, has a critical and specific role in modulating anxiety-related behaviour in mice. Neuron-specific p38α-knockout mice show increased levels of anxiety in behaviour tests, yet no other behavioural, cognitive or motor deficits. Using CRISPR-mediated deletion of p38α in cells, we show that p38α inhibits c-Jun N-terminal kinase (JNK) activity, a function that is specific to p38α over other p38 kinases. Consistently, brains of neuron-specific p38α-knockout mice show increased JNK activity. Inhibiting JNK using a specific blood-brain barrier-permeable inhibitor reduces JNK activity in brains of p38α-knockout mice to physiological levels and reverts anxiety behaviour. Thus, our results suggest that neuronal p38α negatively regulates JNK activity that is required for specific modulation of anxiety-related behaviour.
- 6 July 2018
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 10 (30) , 25127-25134
Peptide Nanofiber Substrates for Long-Term Culturing of Primary Neurons
The culturing of primary neurons represents a central pillar of neuroscience research. Primary neurons are derived directly from brain tissue and recapitulate key aspects of neuronal development in an in vitro setting. Unlike neural stem cells, primary neurons do not divide, thus initial attachment of cells to a suitable substrate is critical. Commonly used poly-lysine substrates can suffer from batch variability owing to their polymeric nature. Herein we report the use of chemically well-defined, self-assembling tetrapeptides as substrates for primary neuronal culture. These water soluble peptides assemble into fibres which facilitate adhesion and development of primary neurons, their long-term survival (>40 days), synaptic maturation and electrical activity. Furthermore, these substrates are permissive towards neuronal transfection and transduction, which coupled with their uniformity and reproducible nature, make them suitable for a wide variety of applications in neuroscience.
- 6 July 2018
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 10 (30) , 25127-25134
Peptide Nanofiber Substrates for Long-Term Culturing of Primary Neurons
The culturing of primary neurons represents a central pillar of neuroscience research. Primary neurons are derived directly from brain tissue and recapitulate key aspects of neuronal development in an in vitro setting. Unlike neural stem cells, primary neurons do not divide, thus initial attachment of cells to a suitable substrate is critical. Commonly used poly-lysine substrates can suffer from batch variability owing to their polymeric nature. Herein we report the use of chemically well-defined, self-assembling tetrapeptides as substrates for primary neuronal culture. These water soluble peptides assemble into fibres which facilitate adhesion and development of primary neurons, their long-term survival (>40 days), synaptic maturation and electrical activity. Furthermore, these substrates are permissive towards neuronal transfection and transduction, which coupled with their uniformity and reproducible nature, make them suitable for a wide variety of applications in neuroscience.
- Open Access
- 1 March 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (10) , 3710-3719
An N-terminal motif unique to primate tau enables differential protein–protein interactions
- 1 March 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (10) , 3710-3719
Open AccessAn N-terminal motif unique to primate tau enables differential protein–protein interactions
- 20 February 2018
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 62 (2) , 571-578
Generation of a New Tau Knockout (tau Δex1 ) Line Using CRISPR/Cas9 Genome Editing in Mice
Alzheimer’s disease and other dementias present with tau pathology. Several mouse lines with knockout of the tau-encoding Mapt gene have been reported, yet findings often differed between lines and sites. Here, we report a new tau knockout strain (tau Δex1 ), generated by CRISPR/Cas9-mediated genome editing of intron -1/exon 1 of Mapt in C57Bl/6J mice. Tau Δex1 mice had no overt phenotype, but, in line with previous models, they showed a significantly reduced susceptibility to excitotoxic seizures, with normal memory formation in young mice. This new in vivo resource will be made freely available to the research community.
- 20 February 2018
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 62 (2) , 571-578
Generation of a New Tau Knockout (tau Δex1 ) Line Using CRISPR/Cas9 Genome Editing in Mice
Alzheimer’s disease and other dementias present with tau pathology. Several mouse lines with knockout of the tau-encoding Mapt gene have been reported, yet findings often differed between lines and sites. Here, we report a new tau knockout strain (tau Δex1 ), generated by CRISPR/Cas9-mediated genome editing of intron -1/exon 1 of Mapt in C57Bl/6J mice. Tau Δex1 mice had no overt phenotype, but, in line with previous models, they showed a significantly reduced susceptibility to excitotoxic seizures, with normal memory formation in young mice. This new in vivo resource will be made freely available to the research community.
- 18 November 2016
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 354 (6314) , 904-908
Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice
Tau phosphorylation—not all bad: Alzheimer's disease presents with amyloid-β (Aβ) plaques and tau tangles. The prevailing idea in the field is that Aβ induces phosphorylation of tau, which in turn mediates neuronal dysfunction. Working in Alzheimer's disease mouse models, Ittner et al. found evidence for a protective role of tau in early Alzheimer's disease. This protection involves specific tau phosphorylation at threonine 205 at the postsynapse. A protective role of phosphorylated tau in disease challenges the dogma that tau phosphorylation only mediates toxic processes. Science , this issue p. 904
- 18 November 2016
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 354 (6314) , 904-908
Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice
Tau phosphorylation—not all bad: Alzheimer's disease presents with amyloid-β (Aβ) plaques and tau tangles. The prevailing idea in the field is that Aβ induces phosphorylation of tau, which in turn mediates neuronal dysfunction. Working in Alzheimer's disease mouse models, Ittner et al. found evidence for a protective role of tau in early Alzheimer's disease. This protection involves specific tau phosphorylation at threonine 205 at the postsynapse. A protective role of phosphorylated tau in disease challenges the dogma that tau phosphorylation only mediates toxic processes. Science , this issue p. 904
- 1 January 2015
- Vol. 7 (3) , 640-653
Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma
Neoadjuvant chemotherapy in osteosarcoma increased the long-term survival of patients with localized disease considerably but metastasizing osteosarcoma remained largely treatment resistant. Neuropilins, transmembrane glycoproteins, are important receptors for VEGF dependent hyper-vascularization in tumor angiogenesis and their aberrant expression promotes tumorigenesis and metastasis in many solid tumors. Our analysis of Neuropilin-1 ( NRP1) and Neuropilin-2 ( NRP2) immunostaining in a tissue microarray of 66 osteosarcoma patients identified NRP2 as an indicator of poor overall, metastasis-free and progression free survival while NRP1 had no predictive value. Patients with tumors that expressed NRP2 in the absence of NRP1 had a significantly worse prognosis than NRP1(-)/NRP2(-), NRP1+ or NRP1(+)/NRP2(+) tumors. Moreover, patients with overt metastases and with NRP2-positive primary tumors had a significantly shorter survival rate than patients with metastases but NRP2-negative tumors. Furthermore, the expression of both NRP1 and NRP2 in osteosarcoma cell lines correlated to a variable degree with the metastatic potential of the respective cell line. To address the functional relevance of Neuropilins for VEGF signaling we used shRNA mediated down-regulation and blocking antibodies of NRP1 and NRP2 in the metastatic 143B and HuO9-M132 cell lines. In 143B cells, VEGFA signaling monitored by AKT phosphorylation was more inhibited by blocking of NRP1, whereas in HuO9-M132 cells NRP2 blocking was more effective indicating that NRP1 and NRP2 can substitute each other in the functional interaction with VEGFR1. Altogether, these data point to NRP2 as a powerful prognostic marker in osteosarcoma and together with NRP1 as a novel target for tumor-suppressive therapy.
- 1 January 2015
- Vol. 7 (3) , 640-653
Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma
Neoadjuvant chemotherapy in osteosarcoma increased the long-term survival of patients with localized disease considerably but metastasizing osteosarcoma remained largely treatment resistant. Neuropilins, transmembrane glycoproteins, are important receptors for VEGF dependent hyper-vascularization in tumor angiogenesis and their aberrant expression promotes tumorigenesis and metastasis in many solid tumors. Our analysis of Neuropilin-1 ( NRP1) and Neuropilin-2 ( NRP2) immunostaining in a tissue microarray of 66 osteosarcoma patients identified NRP2 as an indicator of poor overall, metastasis-free and progression free survival while NRP1 had no predictive value. Patients with tumors that expressed NRP2 in the absence of NRP1 had a significantly worse prognosis than NRP1(-)/NRP2(-), NRP1+ or NRP1(+)/NRP2(+) tumors. Moreover, patients with overt metastases and with NRP2-positive primary tumors had a significantly shorter survival rate than patients with metastases but NRP2-negative tumors. Furthermore, the expression of both NRP1 and NRP2 in osteosarcoma cell lines correlated to a variable degree with the metastatic potential of the respective cell line. To address the functional relevance of Neuropilins for VEGF signaling we used shRNA mediated down-regulation and blocking antibodies of NRP1 and NRP2 in the metastatic 143B and HuO9-M132 cell lines. In 143B cells, VEGFA signaling monitored by AKT phosphorylation was more inhibited by blocking of NRP1, whereas in HuO9-M132 cells NRP2 blocking was more effective indicating that NRP1 and NRP2 can substitute each other in the functional interaction with VEGFR1. Altogether, these data point to NRP2 as a powerful prognostic marker in osteosarcoma and together with NRP1 as a novel target for tumor-suppressive therapy.
- Open Access
- 21 October 2014
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 2 (1) , 1-17
p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer’s disease
Hypersynchronicity of neuronal brain circuits is a feature of Alzheimer’s disease (AD). Mouse models of AD expressing mutated forms of the amyloid-β precursor protein (APP), a central protein involved in AD pathology, show cortical hypersynchronicity. We studied hippocampal circuitry in APP23 transgenic mice using telemetric electroencephalography (EEG), at the age of onset of memory deficits. APP23 mice display spontaneous hypersynchronicity in the hippocampus including epileptiform spike trains. Furthermore, spectral contributions of hippocampal theta and gamma oscillations are compromised in APP23 mice, compared to non-transgenic controls. Using cross-frequency coupling analysis, we show that hippocampal gamma amplitude modulation by theta phase is markedly impaired in APP23 mice. Hippocampal hypersynchronicity and waveforms are differentially modulated by injection of riluzole and the non-competitive N-methyl-D-aspartate (NMDA) receptor inhibitor MK801, suggesting specific involvement of voltage-gated sodium channels and NMDA receptors in hypersynchronicity thresholds in APP23 mice. Furthermore, APP23 mice show marked activation of p38 mitogen-activated protein (MAP) kinase in hippocampus, and injection of MK801 but not riluzole reduces activation of p38 in the hippocampus. A p38 inhibitor induces hypersynchronicity in APP23 mice to a similar extent as MK801, thus supporting suppression of hypersynchronicity involves NMDA receptors-mediated p38 activity. In summary, we characterize components of hippocampal hypersynchronicity, waveform patterns and cross-frequency coupling in the APP23 mouse model by pharmacological modulation, furthering the understanding of epileptiform brain activity in AD.
- 21 October 2014
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 2 (1) , 1-17
Open Accessp38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer’s disease
Hypersynchronicity of neuronal brain circuits is a feature of Alzheimer’s disease (AD). Mouse models of AD expressing mutated forms of the amyloid-β precursor protein (APP), a central protein involved in AD pathology, show cortical hypersynchronicity. We studied hippocampal circuitry in APP23 transgenic mice using telemetric electroencephalography (EEG), at the age of onset of memory deficits. APP23 mice display spontaneous hypersynchronicity in the hippocampus including epileptiform spike trains. Furthermore, spectral contributions of hippocampal theta and gamma oscillations are compromised in APP23 mice, compared to non-transgenic controls. Using cross-frequency coupling analysis, we show that hippocampal gamma amplitude modulation by theta phase is markedly impaired in APP23 mice. Hippocampal hypersynchronicity and waveforms are differentially modulated by injection of riluzole and the non-competitive N-methyl-D-aspartate (NMDA) receptor inhibitor MK801, suggesting specific involvement of voltage-gated sodium channels and NMDA receptors in hypersynchronicity thresholds in APP23 mice. Furthermore, APP23 mice show marked activation of p38 mitogen-activated protein (MAP) kinase in hippocampus, and injection of MK801 but not riluzole reduces activation of p38 in the hippocampus. A p38 inhibitor induces hypersynchronicity in APP23 mice to a similar extent as MK801, thus supporting suppression of hypersynchronicity involves NMDA receptors-mediated p38 activity. In summary, we characterize components of hippocampal hypersynchronicity, waveform patterns and cross-frequency coupling in the APP23 mouse model by pharmacological modulation, furthering the understanding of epileptiform brain activity in AD.
- 1 August 2014
- Published by Wiley in Journal of Neurochemistry
- Vol. 132 (1) , 135-145
Tau‐targeting passive immunization modulates aspects of pathology in tau transgenic mice
Immunization is increasingly recognized as a suitable therapeutic avenue for the treatment of neurological diseases such as Alzheimer's disease and other tauopathies. Tau is a key molecular player in these conditions and therefore represents an attractive target for passive immunization approaches. We performed such an approach in two independent tau transgenic mouse models of tauopathy, K369I tau transgenic K3 and P301L tau transgenic pR5 mice. The antibodies we used were either specific for full‐length tau or tau phosphorylated at serine 404 (pS404), a residue that forms part of the paired helical filament (PHF)‐1 phosphoepitope that characterizes tau neurofibrillary tangles in tauopathies. Although both pS404 antibodies had a similar affinity, they differed in isotype, and only passive immunization with the IgG2a/κ pS404‐specific antibody resulted in a lower tangle burden and reduced phosphorylation of tau at the PHF1 epitope in K3 mice. In pR5 mice, the same antibody led to a reduced phosphorylation of the pS422 and PHF1 epitopes of tau. In addition, histological sections of the hippocampal dentate gyrus of the immunized pR5 mice displayed reduced pS422 staining intensities. These results show that passive immunization targeting tau can modulate aspects of tau pathology in tau transgenic mouse models, in an antibody isotype‐specific manner. image We show that passive immunization targeting the pathological phosphorylation site pS404 on human tau with a monoclonal IgG2a/κ, but not a IgG1/κ antibody, reduced hyperphosphorylation of tau and tangle burden in two independent mouse models of tau pathology. This shows that both specificity and isotype of phospho‐tau (p‐tau)‐specific antibodies are important for therapeutically ameliorating tau pathology.
- 1 August 2014
- Published by Wiley in Journal of Neurochemistry
- Vol. 132 (1) , 135-145
Tau‐targeting passive immunization modulates aspects of pathology in tau transgenic mice
Immunization is increasingly recognized as a suitable therapeutic avenue for the treatment of neurological diseases such as Alzheimer's disease and other tauopathies. Tau is a key molecular player in these conditions and therefore represents an attractive target for passive immunization approaches. We performed such an approach in two independent tau transgenic mouse models of tauopathy, K369I tau transgenic K3 and P301L tau transgenic pR5 mice. The antibodies we used were either specific for full‐length tau or tau phosphorylated at serine 404 (pS404), a residue that forms part of the paired helical filament (PHF)‐1 phosphoepitope that characterizes tau neurofibrillary tangles in tauopathies. Although both pS404 antibodies had a similar affinity, they differed in isotype, and only passive immunization with the IgG2a/κ pS404‐specific antibody resulted in a lower tangle burden and reduced phosphorylation of tau at the PHF1 epitope in K3 mice. In pR5 mice, the same antibody led to a reduced phosphorylation of the pS422 and PHF1 epitopes of tau. In addition, histological sections of the hippocampal dentate gyrus of the immunized pR5 mice displayed reduced pS422 staining intensities. These results show that passive immunization targeting tau can modulate aspects of tau pathology in tau transgenic mouse models, in an antibody isotype‐specific manner. image We show that passive immunization targeting the pathological phosphorylation site pS404 on human tau with a monoclonal IgG2a/κ, but not a IgG1/κ antibody, reduced hyperphosphorylation of tau and tangle burden in two independent mouse models of tau pathology. This shows that both specificity and isotype of phospho‐tau (p‐tau)‐specific antibodies are important for therapeutically ameliorating tau pathology.